161 related articles for article (PubMed ID: 34931329)
1. Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
Martora F; Picone V; Fornaro L; Fabbrocini G; Marasca C
J Med Virol; 2022 Apr; 94(4):1292-1293. PubMed ID: 34931329
[No Abstract] [Full Text] [Related]
2. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Shin SH; Hong JK; Hong SA; Li K; Yoo KH
Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
[No Abstract] [Full Text] [Related]
3. Atypical pityriasis rosea associated with mRNA COVID-19 vaccine.
Bostan E; Jarbou A
J Med Virol; 2022 Mar; 94(3):814-816. PubMed ID: 34585750
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
Welsh E; Cardenas-de la Garza JA; Cuellar-Barboza A; Franco-Marquez R; Arvizu-Rivera RI
Br J Dermatol; 2021 Jun; 184(6):1194-1195. PubMed ID: 33511657
[No Abstract] [Full Text] [Related]
5. Pityriasis rosea and COVID-19.
Veraldi S; Spigariolo CB
J Med Virol; 2021 Jul; 93(7):4068. PubMed ID: 33205836
[No Abstract] [Full Text] [Related]
6. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
Gökçek GE; Öksüm Solak E; Çölgeçen E
Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
[No Abstract] [Full Text] [Related]
7. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
Adya KA; Inamadar AC; Albadri W
Dermatol Ther; 2021 Sep; 34(5):e15040. PubMed ID: 34165237
[No Abstract] [Full Text] [Related]
8. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Birlutiu V; Birlutiu RM; Iancu GM
Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
[TBL] [Abstract][Full Text] [Related]
9. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea.
Alzahrani NA; AlJasser MI
Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Martín Enguix D; Salazar Nievas MDC; Martín Romero DT
Med Clin (Barc); 2020 Sep; 155(6):273. PubMed ID: 32654832
[No Abstract] [Full Text] [Related]
11. Unilateral pityriasis rosea in a child: A rare clinical presentation.
Oğrum A
Turk J Pediatr; 2017; 59(2):214-216. PubMed ID: 29276879
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis rosea after mRNA COVID-19 vaccination.
Abdullah L; Hasbani D; Kurban M; Abbas O
Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
[No Abstract] [Full Text] [Related]
13. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
[No Abstract] [Full Text] [Related]
14. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
[No Abstract] [Full Text] [Related]
15. Atypical pityriasis rosea: clinical evaluation of 27 patients.
Kilinc F; Akbas A; Sener S; Aktaş A
Cutan Ocul Toxicol; 2017 Jun; 36(2):157-162. PubMed ID: 27558764
[TBL] [Abstract][Full Text] [Related]
16. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Cohen OG; Clark AK; Milbar H; Tarlow M
Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
[TBL] [Abstract][Full Text] [Related]
18. Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
Martora F; Picone V; Battista T; Fabbrocini G; Marasca C
Dermatol Ther; 2022 Aug; 35(8):e15602. PubMed ID: 35622446
[No Abstract] [Full Text] [Related]
19. Atypical pityriasis rosea and Hodgkin's disease.
Garcia-F-Villalta MJ; Hernández-Nuñez A; Córdoba S; Fernández-Herrera J; García-Díez A
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):81-2. PubMed ID: 14678538
[TBL] [Abstract][Full Text] [Related]
20. Localized pityriasis rosea.
Ahmed I; Charles-Holmes R
Clin Exp Dermatol; 2000 Nov; 25(8):624-6. PubMed ID: 11167977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
